Pfizer details mRNA flu vaccine data, but revises timeline - Endpoints News
- Pfizer details mRNA flu vaccine data, but revises timeline Endpoints News
- Pfizer's mRNA flu vaccine hits primary goals in phase 3 trial, but secondary miss raises questions FierceBiotech
- Unlike Pfizer, Moderna can meet 2023 COVID forecast, analysts say Reuters.com
- Next-generation influenza B vaccines provide broad and long-lasting protection against flu viruses in preclinical tests Medical Xpress
- New omicron sublineages surge, but Pfizer-BioNTech bivalent booster retains effectiveness News-Medical.Net
- View Full Coverage on Google News